Gene Editing Tool CRISPR Used To Correct Blood Clotting, Treat Hemophilia In Mice The CRISPR gene editing system was used by a pioneering research aiming to treat hemophilia B. In order to eliminate the rare genetic condition, the researchers used mice in their experiments. by Livia Rusu
Healthy Living/Wellness Betting Big on Gene Therapy: Pfizer Partners with Spark Therapeutics for Hemophilia Treatment by Rhodi Lee
Healthy Living/Wellness FDA approves hemophilia B drug Alprolix for children and adults by Lori Sandoval
Healthy Living/Wellness Hemophilia B drug Alprolix given the go-ahead in Canada, with U.S. approval imminent by Tabitha Laffernis